
IP Osgoode is an independent voice that explores legal governance issues at the intersection of intellectual property (IP) and technology. The program’s researchers, collaborators, and students actively engage in some of the most important and cutting-edge IP law and technology related research and policy discussions of today.
Commentary and analysis on the latest developments in intellectual property, technology and privacy, featuring curated contributions from students, scholars, and experts within the Osgoode community.
This April, the United States Court of Appeals ruled that Sergey Aleynikov, former Goldman Sachs software developer-turned convicted thief and spy, was wrongly charged and convicted of theft and espionage under the rationale that software code is not physical property and thereby not subject to theft. This ruling sparks the debate about whether criminal courts […]
Throughout last weekend’s second annual lawTechCamp, audience members interacted with each other using the Twitter hashtag #ltcto2012. While many participants chose not to hide their online identity behind a veil of anonymity, this possibility currently exists without privacy concerns. Sahar Zomorodi’s session, “Dissecting the term ‘lawful access’ in the proposed Online Surveillance Bill C-30,” illustrated Bill C-30’s privacy issues and […]
The copyright and patent dispute between Oracle and Google continues, however a partial verdict on the copyright side of the debate has been handed down.
As the author of the highly publicized decisions of Kerwhizz and Temple Island Collections, Judge Birss of the England and Wales Patent County Court (PCC) is no stranger to controversy. In his latest judgment, Suh v Ryu, Birss J appeared to settle a relatively straightforward procedural matter. Closer scrutiny reveals that his reasons are reflective […]
The issue at the heart of Sullivan v. Bristol Film Studios is not merely the trivial amount of damages. Instead, the analysis from this recent case puts the principle of proportionality front and centre.
Normally, doing something that breaks the law earns you a punishment, including a fine, community service, or even imprisonment. However, when Apotex Inc., a large generic pharmaceutical company, began producing and selling a drug that Servier Laboratories Limited, another large pharmaceutical company, had patented, Apotex was awarded $17.5 million.
Editor in Chief: Prof. Carys Craig (ccraig@osgoode.yorku.ca)
Submission inquiries: iposgoode@osgoode.yorku.ca